Funding Tracker/Cradle
Pharma collaboration · Pharma & Drug Discovery · Switzerland
Cradle: Pharma collaboration
Announced November 4, 2026
The round
The SignalUCB will apply Cradle's AI protein design platform to selected antibody discovery projects, from hit generation through lead optimization and preclinical readiness, in a lab-in-the-loop approach combining computational design with wet-lab validation. Financial terms were not disclosed.
- Company
- Cradle
- Consideration
- Undisclosed
- Stage
- Pharma collaboration
- Announced
- November 4, 2026
- Led by
- Not disclosed
- Other investors
- Partner: UCB
- Vertical
- Pharma & Drug Discovery
- Country
- Switzerland